Predictive Oncology (NASDAQ:POAI) Posts Quarterly Earnings Results

Predictive Oncology (NASDAQ:POAIGet Free Report) posted its quarterly earnings results on Tuesday. The medical instruments supplier reported ($1.04) earnings per share for the quarter, Zacks reports. Predictive Oncology had a negative net margin of 785.62% and a negative return on equity of 104.21%. The firm had revenue of $0.42 million for the quarter.

Predictive Oncology Price Performance

NASDAQ:POAI traded down $0.01 during midday trading on Wednesday, hitting $1.74. The company’s stock had a trading volume of 28,712 shares, compared to its average volume of 122,502. The firm’s 50 day moving average is $2.03 and its 200-day moving average is $2.74. Predictive Oncology has a fifty-two week low of $1.12 and a fifty-two week high of $7.12. The firm has a market cap of $7.04 million, a P/E ratio of -0.50 and a beta of 1.39.

Predictive Oncology Company Profile

(Get Free Report)

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.

Featured Stories

Earnings History for Predictive Oncology (NASDAQ:POAI)

Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.